Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mehmet K Samur

Showing results (1-10 of 47) with videos related to

Pageof 5
Sort By:
Blood|December 8, 2025
Evolution of Multiple Myeloma from a Genomic PerspectiveFrancesco Maura, Mehmet K Samur, Nikhil C Munshi
Nature Communications|May 16, 2024
Bone marrow stromal cells induce chromatin remodeling in multiple myeloma cells leading to transcriptional changesMoritz Binder, Raphael E Szalat, Srikanth Talluri, et al.
BMC Genomics|October 4, 2013
The shaping and functional consequences of the dosage effect landscape in multiple myelomaMehmet K Samur, Parantu K Shah, Xujun Wang, et al.
Oncotarget|December 2, 2021
CCL20 induces colorectal cancer neoplastic epithelial cell proliferation, migration, and further CCL20 production through autocrine HGF-c-Met and MSP-MSPR signaling pathwaysBisweswar Nandi, Jonathan Pastrana Del Valle, Mehmet K Samur, et al.
Blood Cancer Journal|October 11, 2018
Role of apurinic/apyrimidinic nucleases in the regulation of homologous recombination in myeloma: mechanisms and translational significanceSubodh Kumar, Srikanth Talluri, Jagannath Pal, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 27, 2017
Ribonucleotide Reductase Catalytic Subunit M1 (RRM1) as a Novel Therapeutic Target in Multiple MyelomaMorihiko Sagawa, Hiroto Ohguchi, Takeshi Harada, et al.
Cancer Immunology, Immunotherapy : CII|November 13, 2015
Deficiency of IL-17A, but not the prototypical Th17 transcription factor RORγt, decreases murine spontaneous intestinal tumorigenesisMia Shapiro, Bisweswar Nandi, Christine Pai, et al.
Blood|August 27, 2020
The JAK-STAT pathway regulates CD38 on myeloma cells in the bone marrow microenvironment: therapeutic implicationsDaisuke Ogiya, Jiye Liu, Hiroto Ohguchi, et al.
Blood Cancer Journal|October 9, 2021
Dysregulated APOBEC3G causes DNA damage and promotes genomic instability in multiple myelomaSrikanth Talluri, Mehmet K Samur, Leutz Buon, et al.
Oncoimmunology|September 14, 2016
Stromal CCR6 drives tumor growth in a murine transplantable colon cancer through recruitment of tumor-promoting macrophagesBisweswar Nandi, Mia Shapiro, Mehmet K Samur, et al.
Pageof 5

Showing results (1-10 of 47) with videos related to

Sort By:
Pageof 5
Blood|December 8, 2025
Evolution of Multiple Myeloma from a Genomic PerspectiveFrancesco Maura, Mehmet K Samur, Nikhil C Munshi
Nature Communications|May 16, 2024
Bone marrow stromal cells induce chromatin remodeling in multiple myeloma cells leading to transcriptional changesMoritz Binder, Raphael E Szalat, Srikanth Talluri, et al.
BMC Genomics|October 4, 2013
The shaping and functional consequences of the dosage effect landscape in multiple myelomaMehmet K Samur, Parantu K Shah, Xujun Wang, et al.
Oncotarget|December 2, 2021
CCL20 induces colorectal cancer neoplastic epithelial cell proliferation, migration, and further CCL20 production through autocrine HGF-c-Met and MSP-MSPR signaling pathwaysBisweswar Nandi, Jonathan Pastrana Del Valle, Mehmet K Samur, et al.
Blood Cancer Journal|October 11, 2018
Role of apurinic/apyrimidinic nucleases in the regulation of homologous recombination in myeloma: mechanisms and translational significanceSubodh Kumar, Srikanth Talluri, Jagannath Pal, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 27, 2017
Ribonucleotide Reductase Catalytic Subunit M1 (RRM1) as a Novel Therapeutic Target in Multiple MyelomaMorihiko Sagawa, Hiroto Ohguchi, Takeshi Harada, et al.
Cancer Immunology, Immunotherapy : CII|November 13, 2015
Deficiency of IL-17A, but not the prototypical Th17 transcription factor RORγt, decreases murine spontaneous intestinal tumorigenesisMia Shapiro, Bisweswar Nandi, Christine Pai, et al.
Blood|August 27, 2020
The JAK-STAT pathway regulates CD38 on myeloma cells in the bone marrow microenvironment: therapeutic implicationsDaisuke Ogiya, Jiye Liu, Hiroto Ohguchi, et al.
Blood Cancer Journal|October 9, 2021
Dysregulated APOBEC3G causes DNA damage and promotes genomic instability in multiple myelomaSrikanth Talluri, Mehmet K Samur, Leutz Buon, et al.
Oncoimmunology|September 14, 2016
Stromal CCR6 drives tumor growth in a murine transplantable colon cancer through recruitment of tumor-promoting macrophagesBisweswar Nandi, Mia Shapiro, Mehmet K Samur, et al.
Pageof 5